Moors & Cabot Inc. lifted its holdings in Core Laboratories N.V. (NYSE:CLB) by 1.1% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 15,902 shares of the oil and gas company’s stock after purchasing an additional 168 shares during the period. Moors & Cabot Inc.’s holdings in Core Laboratories N.V. were worth $1,614,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also made changes to their positions in the company. Parallel Advisors LLC increased its stake in shares of Core Laboratories N.V. by 33.4% in the 1st quarter. Parallel Advisors LLC now owns 891 shares of the oil and gas company’s stock valued at $101,000 after purchasing an additional 223 shares in the last quarter. Quantbot Technologies LP purchased a new position in shares of Core Laboratories N.V. in the 1st quarter valued at about $106,000. FNY Managed Accounts LLC purchased a new position in shares of Core Laboratories N.V. in the 1st quarter valued at about $123,000. Shine Investment Advisory Services Inc. purchased a new position in shares of Core Laboratories N.V. in the 2nd quarter valued at about $134,000. Finally, First Bank & Trust increased its stake in shares of Core Laboratories N.V. by 5.8% in the 2nd quarter. First Bank & Trust now owns 1,493 shares of the oil and gas company’s stock valued at $152,000 after purchasing an additional 82 shares in the last quarter.

Several equities analysts recently weighed in on the company. Cowen and Company set a $100.00 price target on Core Laboratories N.V. and gave the company a “hold” rating in a research note on Friday. Zacks Investment Research cut Core Laboratories N.V. from a “hold” rating to a “sell” rating in a report on Tuesday, September 26th. Royal Bank Of Canada lowered their price objective on Core Laboratories N.V. from $115.00 to $112.00 and set an “outperform” rating on the stock in a report on Thursday, September 7th. ValuEngine cut Core Laboratories N.V. from a “hold” rating to a “sell” rating in a report on Friday, September 1st. Finally, Credit Suisse Group upgraded Core Laboratories N.V. from a “neutral” rating to an “outperform” rating and set a $110.00 price objective on the stock in a report on Thursday, August 24th. They noted that the move was a valuation call. Four investment analysts have rated the stock with a sell rating, eight have assigned a hold rating and four have assigned a buy rating to the company. Core Laboratories N.V. has a consensus rating of “Hold” and a consensus target price of $111.10.

Shares of Core Laboratories N.V. (NYSE CLB) traded down 1.80% on Friday, hitting $94.26. The stock had a trading volume of 509,425 shares. The company’s 50 day moving average is $93.57 and its 200 day moving average is $102.76. The stock has a market cap of $4.16 billion, a PE ratio of 57.83 and a beta of 1.64. Core Laboratories N.V. has a one year low of $86.55 and a one year high of $125.83.

Core Laboratories N.V. (NYSE:CLB) last announced its earnings results on Monday, July 24th. The oil and gas company reported $0.52 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.51 by $0.01. Core Laboratories N.V. had a net margin of 11.80% and a return on equity of 49.29%. The firm had revenue of $163.90 million for the quarter, compared to analyst estimates of $168.23 million. During the same quarter last year, the business earned $0.35 earnings per share. Core Laboratories N.V.’s revenue was up 10.7% compared to the same quarter last year. Equities research analysts predict that Core Laboratories N.V. will post $1.99 EPS for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: This piece of content was first posted by Watch List News and is the property of of Watch List News. If you are accessing this piece of content on another domain, it was illegally copied and reposted in violation of international trademark & copyright legislation. The legal version of this piece of content can be accessed at https://www.watchlistnews.com/core-laboratories-n-v-clb-position-boosted-by-moors-cabot-inc/1615691.html.

Core Laboratories N.V. Profile

Core Laboratories N.V. provides reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company operates through three segments: Reservoir Description, Production Enhancement and Reservoir Management. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples.

Institutional Ownership by Quarter for Core Laboratories N.V. (NYSE:CLB)

Receive News & Ratings for Core Laboratories N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories N.V. and related companies with Analyst Ratings Network's FREE daily email newsletter.